Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors

IMPORTANCE: The development of oncology drugs is expensive and beset by a high attrition rate. Analysis of the costs and causes of translational failure may help to reduce attrition and permit the more appropriate use of resources to reduce mortality from cancer. OBJECTIVE: To analyze the causes of...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzsch, Valerie, Osipenko, Leeza, Scannell, Jack W., Hickman, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383012/
https://www.ncbi.nlm.nih.gov/pubmed/37505498
http://dx.doi.org/10.1001/jamanetworkopen.2023.24977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10383012/
https://www.ncbi.nlm.nih.gov/pubmed/37505498
http://dx.doi.org/10.1001/jamanetworkopen.2023.24977

Ejemplares similares